Clinical Trial Update: Stereotactic Body Radiation Therapy (SBRT) in Liver Metastasis (COLD 3) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating stereotactic body radiation therapy (SBRT) for liver metastasis has completed accrual and status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastasis

Snippet

Sponsor: University Health Network, Toronto | Conditions: Liver Metastasis | Phase 2 | Status: COMPLETED